Alkermes PLC (ALKS)
27.70
-0.21
(-0.75%)
USD |
NASDAQ |
Nov 21, 16:00
27.70
0.00 (0.00%)
After-Hours: 20:00
Alkermes Enterprise Value: 3.862B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 3.862B |
| November 20, 2024 | 3.896B |
| November 19, 2024 | 3.826B |
| November 18, 2024 | 3.838B |
| November 15, 2024 | 3.941B |
| November 14, 2024 | 3.967B |
| November 13, 2024 | 4.111B |
| November 12, 2024 | 4.109B |
| November 11, 2024 | 4.246B |
| November 08, 2024 | 4.050B |
| November 07, 2024 | 4.067B |
| November 06, 2024 | 4.119B |
| November 05, 2024 | 3.970B |
| November 04, 2024 | 3.682B |
| November 01, 2024 | 3.663B |
| October 31, 2024 | 3.538B |
| October 30, 2024 | 3.637B |
| October 29, 2024 | 3.658B |
| October 28, 2024 | 3.673B |
| October 25, 2024 | 3.601B |
| October 24, 2024 | 3.724B |
| October 23, 2024 | 3.886B |
| October 22, 2024 | 3.927B |
| October 21, 2024 | 3.864B |
| October 18, 2024 | 3.954B |
| Date | Value |
|---|---|
| October 17, 2024 | 3.963B |
| October 16, 2024 | 3.924B |
| October 15, 2024 | 3.910B |
| October 14, 2024 | 4.080B |
| October 11, 2024 | 4.057B |
| October 10, 2024 | 3.808B |
| October 09, 2024 | 3.682B |
| October 08, 2024 | 3.766B |
| October 07, 2024 | 3.876B |
| October 04, 2024 | 4.067B |
| October 03, 2024 | 3.970B |
| October 02, 2024 | 4.071B |
| October 01, 2024 | 4.044B |
| September 30, 2024 | 3.908B |
| September 27, 2024 | 3.947B |
| September 26, 2024 | 3.887B |
| September 25, 2024 | 3.766B |
| September 24, 2024 | 3.920B |
| September 23, 2024 | 4.041B |
| September 20, 2024 | 4.115B |
| September 19, 2024 | 4.082B |
| September 18, 2024 | 3.996B |
| September 17, 2024 | 3.981B |
| September 16, 2024 | 3.996B |
| September 13, 2024 | 3.968B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.666B
Minimum
Mar 18 2020
4.957B
Maximum
Feb 15 2024
3.424B
Average
3.564B
Median
Feb 01 2022
Enterprise Value Benchmarks
| Jazz Pharmaceuticals PLC | 11.06B |
| Medtronic PLC | 129.24B |
| Perrigo Co PLC | 6.985B |
| Iterum Therapeutics PLC | 31.18M |
| Mallinckrodt PLC | 1.332B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 92.38M |
| Revenue (Quarterly) | 378.14M |
| Total Expenses (Quarterly) | 273.39M |
| EPS Diluted (Quarterly) | 0.55 |
| Gross Profit Margin (Quarterly) | 83.31% |
| Profit Margin (Quarterly) | 24.43% |
| Earnings Yield | 7.04% |
| Operating Earnings Yield | 6.66% |
| Normalized Earnings Yield | 8.231 |